• VIDEO: Avicenna Alliance
    at the European Parliament

    At the invitation of the European Parliament, Avicenna Alliance's leaders supported by senior people from FDA, ANSYS, Medtronic, CIPLA, VPHi, EFGCP and RPP, have explained to delegations from Europe, USA, India and Japan the central role played by in silico healthcare to accelerate medical innovation.

    View the video!

Avicenna Alliance news

The European Commission, EMA and FDA held their 2020 bilateral regulatory dialogue meeting on 18 and 19 June

Senior Officials from the European Commission (DG SANTE), European Medicines Agency (EMA)...

find out more ›

Avicenna publishes provisional executive summary on “The role of Artificial Intelligence within in silico medicine” and comments on the European Commission’s White Paper on AI

On 12 June, the...

find out more ›

The Avicenna Alliance publishes a brand-new position paper on AI & Big Data while providing feedback on the European Strategy for Data

We are proud to announce that on 29 May, the Avicenna Alliance...

find out more ›

Show all activites

Avicenna Alliance the Association for Predictive Medicine

The Avicenna Alliance, is an association of industry and renowned academia/healthcare organizations who have a commercial or research interest in the development of in silico medicine. The Association, established in 2015, has its origins in the Virtual Physiological Human Initiative, a European Commission endorsed research area on computer modeling and simulation. Tasked by the European Commission with developing a “Roadmap for in silico medicine”, the Association now seeks to put this roadmap into policy and ensure the development of a regulated in silico market.

This Association bridges the gap between the scientific community, industry and policy makers by advocating for policy changes that take into account scientific and market developments.

read more

Avicenna Alliance: 
enhanced knowledge, improved decisions, better outcomes

Sign up for our monthly newsletter!


Sign up